High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis

Autor: Jeremy N. Skepper, Dirk Saerens, Senthil Kumar A. Natesan, Lea Brys, Mark C. Field, Alexandros Nikolaou, Serge Muyldermans, Stefan Magez, Etienne Pays, David Perez-Morga, Katja Conrath, Benoit Stijlemans, Patrick De Baetselier, Guy Caljon
Přispěvatelé: Cellular and Molecular Immunology, Molecular and Biochemical Pharmacology
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Models
Molecular

Trypanocidal Agents -- pharmacology -- therapeutic use
Antibody Affinity
Antibodies
Protozoan

Epitope
Mice
Trypanosome brucei
Down-Regulation -- drug effects
Molecular Cell Biology
Biology (General)
Cells
Cultured

chemistry.chemical_classification
0303 health sciences
biology
trypanosomiasis therapeutics
Trypanosoma brucei brucei -- immunology -- metabolism -- physiology -- ultrastructure
Sciences bio-médicales et agricoles
Trypanocidal Agents
nanobodies
Endocytosis
3. Good health
Cell biology
Antibodies
Protozoan -- immunology -- pharmacology -- therapeutic use

Antibody
Endocytosis -- drug effects
Variant Surface Glycoproteins
Trypanosoma

Sciences exactes et naturelles
Research Article
Biotechnology
trypanolytic agent
Trypanosomiasis
African -- immunology -- metabolism -- therapy

QH301-705.5
Immunology
Molecular Sequence Data
Trypanosoma brucei brucei
Down-Regulation
Trypanosoma brucei
Microbiology
Models
Biological

03 medical and health sciences
Virology
parasitic diseases
Genetics
Antigenic variation
Animals
Humans
Amino Acid Sequence
variant-specific surface glycoprotein
Molecular Biology
Biology
030304 developmental biology
030306 microbiology
Variant Surface Glycoproteins
Trypanosoma -- immunology

RC581-607
biology.organism_classification
Molecular biology
Complement system
Mice
Inbred C57BL

Trypanosomiasis
African

chemistry
biology.protein
Trypanosoma
Nanoparticles
Parasitology
Immunologic diseases. Allergy
Glycoprotein
Zdroj: Vrije Universiteit Brussel
PLoS Pathogens, Vol 7, Iss 6, p e1002072 (2011)
PLoS Pathogens
P L o S Pathogens, 7 (6
Popis: The African trypanosome Trypanosoma brucei, which persists within the bloodstream of the mammalian host, has evolved potent mechanisms for immune evasion. Specifically, antigenic variation of the variant-specific surface glycoprotein (VSG) and a highly active endocytosis and recycling of the surface coat efficiently delay killing mediated by anti-VSG antibodies. Consequently, conventional VSG-specific intact immunoglobulins are non-trypanocidal in the absence of complement. In sharp contrast, monovalent antigen-binding fragments, including 15 kDa nanobodies (Nb) derived from camelid heavy-chain antibodies (HCAbs) recognizing variant-specific VSG epitopes, efficiently lyse trypanosomes both in vitro and in vivo. This Nb-mediated lysis is preceded by very rapid immobilisation of the parasites, massive enlargement of the flagellar pocket and major blockade of endocytosis. This is accompanied by severe metabolic perturbations reflected by reduced intracellular ATP-levels and loss of mitochondrial membrane potential, culminating in cell death. Modification of anti-VSG Nbs through site-directed mutagenesis and by reconstitution into HCAbs, combined with unveiling of trypanolytic activity from intact immunoglobulins by papain proteolysis, demonstrates that the trypanolytic activity of Nbs and Fabs requires low molecular weight, monovalency and high affinity. We propose that the generation of low molecular weight VSG-specific trypanolytic nanobodies that impede endocytosis offers a new opportunity for developing novel trypanosomiasis therapeutics. In addition, these data suggest that the antigen-binding domain of an anti-microbial antibody harbours biological functionality that is latent in the intact immunoglobulin and is revealed only upon release of the antigen-binding fragment.
Evaluation Studies
Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
info:eu-repo/semantics/published
Databáze: OpenAIRE